|
1
|
Celli B, Fabbri L, Criner G, Martinez FJ,
Mannino D, Vogelmeier C, Montes de Oca M, Papi A, Sin DD, Han MK
and Agusti A: Definition and nomenclature of chronic obstructive
pulmonary disease: Time for its revision. Am J Respir Crit Care
Med. 206:1317–1325. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Confalonieri M, Braga L, Salton F, Ruaro B
and Confalonieri P: Chronic obstructive pulmonary disease
definition: Is it time to incorporate the concept of failure of
lung regeneration? Am J Respir Crit Care Med. 207:366–367.
2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Christenson SA, Smith BM, Bafadhel M and
Putcha N: Chronic obstructive pulmonary disease. Lancet.
399:2227–2242. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Perera WR, Hurst JR, Wilkinson TM,
Sapsford RJ, Müllerova H, Donaldson GC and Wedzicha JA:
Inflammatory changes, recovery and recurrence at COPD exacerbation.
Eur Respir J. 29:527–534. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wei Y, Wang S, Wang D and Liu C:
Expression and clinical significance of serum amyloid A and
interleukin-6 in patients with acute exacerbation of chronic
obstructive pulmonary disease. Exp Ther Med. 19:2089–2094.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bridgewood C, Russell T, Weedon H,
Baboolal T, Watad A, Sharif K, Cuthbert R, Wittmann M, Wechalekar M
and McGonagle D: The novel cytokine Metrnl/IL-41 is elevated in
Psoriatic Arthritis synovium and inducible from both entheseal and
synovial fibroblasts. Clin Immunol. 208(108253)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zheng SL, Li ZY, Song J, Liu JM and Miao
CY: Metrnl: A secreted protein with new emerging functions. Acta
Pharmacol Sin. 37:571–579. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ushach I, Arrevillaga-Boni G, Heller GN,
Pone E, Hernandez-Ruiz M, Catalan-Dibene J, Hevezi P and Zlotnik A:
Meteorin-like/Meteorin-β is a novel immunoregulatory cytokine
associated with inflammation. J Immunol. 201:3669–3676.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rao RR, Long JZ, White JP, Svensson KJ,
Lou J, Lokurkar I, Jedrychowski MP, Ruas JL, Wrann CD, Lo JC, et
al: Meteorin-like is a hormone that regulates immune-adipose
interactions to increase beige fat thermogenesis. Cell.
157:1279–1291. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kerget B, Afşin DE, Kerget F, Aşkın S and
Akgün M: Is metrnl an adipokine involved in the anti-inflammatory
response to acute exacerbations of COPD? Lung. 198:307–314.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Golestani R, Razavian M, Ye Y, Zhang J,
Jung JJ, Toczek J, Gona K, Kim HY, Elias JA, Lee CG, et al: Matrix
metalloproteinase-targeted imaging of lung inflammation and
remodeling. J Nucl Med. 58:138–143. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Alrumaihi F: A cheminformatics-biophysics
correlate to identify promising lead molecules against matrix
metalloproteinase-2 (MMP-2) enzyme: A promising anti-cancer target.
Saudi Pharm J. 31:1244–1253. 2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang Y, Li Y, Ye Z and Ma H: Expression
of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue
inhibitor of metalloproteinase-1, and changes in alveolar septa in
patients with chronic obstructive pulmonary disease. Med Sci Monit.
26(e925278)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tanaka M, Takarada T, Nadanaka S, Kojima
R, Hosoi K, Machiba Y, Kitagawa H and Yamada T: Influences of
amino-terminal modifications on amyloid fibril formation of human
serum amyloid A. Arch Biochem Biophys. 742(109615)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Prins HJ, Duijkers R, Kramer G, Boerhout
E, Rietema FJ, de Jong PA, Schoorl MI, van der Werf TS and Boersma
WG: Relationship between biomarkers and findings on low-dose
computed tomography in hospitalised patients with acute
exacerbation of COPD. ERJ Open Res. 8:00054–2022. 2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tan Q, Wang B, Ye Z, Mu G, Liu W, Nie X,
Yu L, Zhou M and Chen W: Cross-sectional and longitudinal
relationships between ozone exposure and glucose homeostasis:
Exploring the role of systemic inflammation and oxidative stress in
a general Chinese urban population. Environ Pollut.
329(121711)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xu B and Han L: Predictive Value of CRP,
PCT and ESR on piperacillin-tazobactam in treating chronic
obstructive pulmonary disease with pneumonia. Clin Lab.
69:2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Han Fang and Bin Zhao: Donghong Liu(2020)
To explore the clinical value of NLR and PLR in the treatment of
acute exacerbation of chronic obstructive pulmonary disease.
General practice clinical and education. 18:694–697. 2020.
|
|
19
|
Venkatesan P: GOLD COPD report: 2024
update. Lancet Respir Med. 12:15–16. 2024.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Celli BR, Fabbri LM, Aaron SD, Agusti A,
Brook R, Criner GJ, Franssen FME, Humbert M, Hurst JR, O'Donnell D,
et al: An updated definition and severity classification of chronic
obstructive pulmonary disease exacerbations: The rome proposal. Am
J Respir Crit Care Med. 204:1251–1258. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Agustí A, Celli BR, Criner GJ, Halpin D,
Anzueto A, Barnes P, Bourbeau J, Han MK, Martinez FJ, Montes de Oca
M, et al: Global initiative for chronic obstructive lung disease
2023 report: GOLD executive summary. Eur Respir J.
61(2300239)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gautam SS and O'Toole RF: Convergence in
the epidemiology and pathogenesis of COPD and pneumonia. COPD.
13:790–798. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Koutsokera A, Kostikas K, Nicod LP and
Fitting JW: Pulmonary biomarkers in COPD exacerbations: A
systematic review. Respir Res. 14(111)2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ramya PA, Mohapatra MM, Saka VK, Kar R,
Chakkalakkoombil SV and Vemuri MB: Haematological and inflammatory
biomarkers among stable COPD and acute exacerbations of COPD
patients. Sultan Qaboos Univ Med J. 23:239–244. 2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xu Haifeng, Sun Yifeng and Lin Huan:
Effects of smoking on immune inflammatory response and pulmonary
function in patients with chronic obstructive pulmonary disease. J
Clin Pulmonol. 25:58–61. 2020.
|
|
26
|
Xian Shaojing and Chen Qingyun: Changes of
lung function and serum cytokine levels in patients with acute
exacerbation of chronic obstructive pulmonary disease and their
correlation with smoking and body mass index. J Clin &
Pathology. 42:144–150. 2021.
|
|
27
|
Murray PJ: Macrophage Polarization. Annu
Rev Physiol. 79:541–566. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bazzan E, Turato G, Tinè M, Radu CM,
Balestro E, Rigobello C, Biondini D, Schiavon M, Lunardi F, Baraldo
S, et al: Dual polarization of human alveolar macrophages
progressively increases with smoking and COPD severity. Respir Res.
18(40)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cen T, Mai Y, Jin J, Huang M, Li M, Wang S
and Ma H: Interleukin-41 diminishes cigarette smoke-induced lung
inflammation in mice. Int Immunopharmacol. 124(Pt
A)(110794)2023.PubMed/NCBI View Article : Google Scholar
|
